Background: This report studies the early and medium-term clinical and echocardio-
alone is adequate in the surgical management of LVOTO in the vast majority of patients with HCM. 5, 6 Concomitant mitral valve repair at the time of SM can be used to prevent or treat post SM systolic anterior motion (SAM)-related mitral regurgitation (MR) or residual unacceptably high LVOT gradients. [7] [8] [9] [10] This approach to SAM which is required in a small number of such patients can avoid mitral valve replacement (MVR) and its associated increased mortality and morbidity. 5, 6, 11, 12 Previous studies using the "edge-to-edge" mitral repair technique described by
Alfieri et al have shown good outcomes in the correction of MR from diverse etiologies such as degenerative, ischemic, and functional. [13] [14] [15] [16] [17] This study investigates early and medium-term outcomes in a group of 11 consecutive patients undergoing an Alfieri mitral valve repair at the time of SM for the prevention and treatment of SAM.
| MATERIALS AND METHODS
A retrospective analysis was carried out in a cohort of patients with HCM who had a SM and Alfieri mitral repair for management of LVOTO by a single surgeon (CMcG). A diagnosis of HCM was defined as per international guidelines. 1 No patient had undergone previous management of LVOTO with surgery, alcohol septal ablation, or dualchamber pacing. Preoperative clinical assessment was undertaken by a team of specialist HCM cardiologists in a national referral center.
Review board ethical approval was obtained for data collection and reporting.
| Patient profiles
The study consisted of 11 consecutive patients, seven males, four 
| Assessment and follow-up
Echocardiograms were assessed preoperatively, postoperatively, and annually. Provocation using Valsalva or exercise echocardiography was performed if clinically indicated. No patients were lost to followup. Perioperative complications were defined as those occurring during hospitalization or within 30 days of surgery. Late complications were defined as those occurring after this period.
| Surgical assessment and technique
Perioperative transesophageal echocardiography (TEE) was performed prior to and following cardiopulmonary bypass. After median sternotomy and before cardiopulmonary bypass, direct simultaneous pressure measurements were performed with needles in the aorta and left ventricle. Provocation was measured following a bolus of
Isoproterenol (5 mcg In addition, direct simultaneous pressure measurements were repeated with and without provocation as done pre-bypass. Indications to resume bypass and perform an Alfieri repair at this point were a significant residual gradient, and/or persistent SAM related-MR. Mitral annuloplasty was avoided in all patients.
| Statistical analysis
Data were analyzed using SPSS Version 24 (IBM Corp., Armonk, NY).
Variables collected included baseline demographics, New York Heart Association (NYHA) clinical classification, echocardiographic parameters (MR grade, SAM, ejection fraction, LVOT gradients), and postoperative outcomes. Variables were expressed as a mean with standard deviation or median with interquartile range as appropriate.
Comparisons were made using paired t-tests. A P-value of <0.05 was considered significant.
| RESULTS
There were no perioperative or late deaths. The median follow-up was 6.6
years (international quartile range 1.2-7.4). No patient was lost to follow-up.
Septal tissue excised at myectomy weighed a mean of 4.3 ± 3.6 g.
Intraoperatively, pre-bypass, the mean resting LVOT gradient was 40.7 ± 19.9 mmHg and on provocation with Isoproterenol was 115.8 ± 30.4 mmHg. Following surgical resection and Alfieri repair, the mean resting LVOT gradient was reduced to 8.3 ± 9.8 mmHg and on provocation was 25.8 ± 9.2 mmHg. The mean hospital stay was 10 ± 3 days.
One patient required a MVR on day 4 postoperatively due to severe MR.
This was a 46-year-old male who preoperatively had a right atrial pressure of 
| DISCUSSION
Isolated septal myectomy is the only surgical procedure required in the vast majority of patients with LVOTO in HCM. 4, 5 The incidence of SM with concomitant mitral valve repair in this study (11 of 123 overall SM cases) is consistent with the 7% reported recently in the largest study to date of over 2000 patients from the Mayo Clinic. 5, 6 A number of surgical techniques have been utilized on the mitral valve to eliminate SAM in the context of SM. [7] [8] [9] [10] The optimal surgical strategy remains uncertain. 5 15 This technique has been studied in larger cohorts undergoing 
